Our results suggested that a combination of AZD5363 and AZD8055 treatment associates with an enhanced accumulation of nuclear FOXO3a leading to Bim induction and promotes programmed cell death in p53 mutated HCC cells. Here, BCL2L11 is linked to hepatocellular carcinoma.